Methylisopropyllysergamide
Methylisopropyllysergamide
Methylisopropyllysergamide (MIPLA) is a chemical compound that belongs to the class of lysergamides, which are derivatives of lysergic acid. MIPLA is structurally related to lysergic acid diethylamide (LSD), a well-known psychedelic substance. The compound is of interest in the field of psychopharmacology due to its potential effects on the central nervous system.
Chemical Structure and Properties
Methylisopropyllysergamide is characterized by the presence of a lysergic acid core with an isopropyl group and a methyl group attached to the amide nitrogen. This modification distinguishes it from other lysergamides such as LSD, which has two ethyl groups attached to the amide nitrogen.
The chemical formula of MIPLA is C20H26N2O, and it has a molecular weight of 310.44 g/mol. The compound is typically synthesized in a laboratory setting and is not found naturally.
Pharmacology
MIPLA is believed to act as a partial agonist at the 5-HT2A receptor, similar to other lysergamides. This receptor is known to play a significant role in the modulation of mood, perception, and cognition, which are often affected by psychedelic substances.
The pharmacokinetics of MIPLA, including its absorption, distribution, metabolism, and excretion, are not well-documented in the scientific literature. However, it is assumed to share some similarities with other lysergamides in terms of its metabolic pathways.
Potential Effects
While specific studies on MIPLA are limited, it is hypothesized to produce effects similar to those of LSD, including altered sensory perception, changes in mood, and cognitive shifts. The intensity and duration of these effects can vary based on dosage, individual physiology, and environmental factors.
Legal Status
The legal status of MIPLA varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to LSD and potential for psychoactive effects. Researchers interested in studying MIPLA must often obtain special licenses or permissions to work with the compound.
Related Compounds
MIPLA is part of a broader class of compounds known as lysergamides, which include:
These compounds share a common lysergic acid backbone but differ in their side chain modifications, which can significantly influence their pharmacological profiles.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD